Fig. 2From: Real-world outcomes of mepolizumab for the treatment of severe eosinophilic asthma in Canada: an observational studyAsthma-related HCRU for patients in the overall PSP population pre- versus post-mepolizumabED, emergency department; GP, general practitioner; HCRU, healthcare resource utilization; PSP, patient support programBack to article page